Shrinidhi Nathany: Why the Theriome Matters More Than We Think
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, posted on LinkedIn:
“Sunday learning with the boss Dr. Rahul Bhargava
After a break back with a bang.. with more new concepts
As i started a thread on theriome, i will continue that today
Why the Theriome Matters More Than We Think
We often ask why patients with the same diagnosis and similar mutations have very different outcomes.
The answer often lies in the theriome.
The theriome influences how aggressively a tumour behaves, how it escapes the immune system and how it responds or fails to respond to therapy. In hematologic malignancies, the bone marrow and lymphoid niche can actively protect malignant cells from chemotherapy and targeted drugs.
This is why genomics alone is sometimes not enough. To truly understand cancer behaviour, we must also understand the ecosystem in which the cancer lives.”
Stay informed with Hemostasis Today.
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?